Quarter Period Statement Of Income

Carna Biosciences, Inc. - Filing #7550971

Concept 2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
2022-01-01 to
2022-06-30
Quarter period statement of income
Statement of income
Net sales
500,570,000 JPY
500,570,000 JPY
JPY
839,543,000 JPY
553,498,000 JPY
286,045,000 JPY
Cost of sales
82,684,000 JPY
83,078,000 JPY
Gross profit (loss)
417,886,000 JPY
756,465,000 JPY
Selling, general and administrative expenses
1,281,582,000 JPY
1,068,482,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-863,696,000 JPY
169,321,000 JPY
-1,033,017,000 JPY
-312,016,000 JPY
235,138,000 JPY
-547,155,000 JPY
Non-operating income
Interest income
84,000 JPY
57,000 JPY
Dividend income
211,000 JPY
204,000 JPY
Non-operating income
2,430,000 JPY
10,576,000 JPY
Non-operating expenses
Interest expenses
1,695,000 JPY
3,063,000 JPY
Non-operating expenses
7,139,000 JPY
4,991,000 JPY
Ordinary profit (loss)
-868,405,000 JPY
-306,431,000 JPY
Extraordinary losses
Impairment losses
984,000 JPY
42,948,000 JPY
Extraordinary losses
984,000 JPY
42,948,000 JPY
Profit (loss) before income taxes
-869,389,000 JPY
-349,379,000 JPY
Income taxes - current
16,275,000 JPY
9,802,000 JPY
Income taxes - deferred
-56,000 JPY
-61,000 JPY
Income taxes
16,218,000 JPY
9,740,000 JPY
Profit (loss)
-885,608,000 JPY
-359,120,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.